ACCU-BREAK™ Technology Platform
Platform for dose-flexible drug reformulation
Key Facts
About Accu-Break Pharmaceuticals
Accu-Break Pharmaceuticals is a private drug delivery technology company founded in 1960 and headquartered in Hollywood (Fort Lauderdale area), Florida. The company's core asset is its ACCU-BREAK™ platform, a patented tablet design featuring an inactive break layer that allows for precise, safe splitting into fractional doses, addressing a significant need in personalized medicine, pediatrics, and geriatrics. Operating as a technology licensor, Accu-Break aims to partner with pharmaceutical companies to reformulate existing or pipeline drugs, offering them a pathway for product differentiation, lifecycle management, and potential patent extension. The company appears to be in a pre-revenue or early partnership stage, leveraging its management's extensive pharmaceutical industry experience to commercialize its platform.
View full company profile